Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Epalrestat (Z, Z)-Isomer
Epalrestat (Z, Z)-Isomer
  • Epalrestat (Z, Z)-Isomer
  • Epalrestat (Z, Z)-Isomer
  • Epalrestat (Z, Z)-Isomer
  • Epalrestat (Z, Z)-Isomer
  • Epalrestat (Z, Z)-Isomer

Epalrestat (Z, Z)-Isomer NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Epalrestat (Z, Z)-Isomer CAS No.: 124782-63-4
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31

Epalrestat (Z, Z)-Isomer


Article illustration

Product Information

  • Product Code:E022004

  • English Name:Epalrestat (Z, Z)-Isomer

  • English Alias:2-((Z)-5-((Z)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid

  • CAS No.:124782-63-4

  • Molecular Formula:C₁₅H₁₃NO₃S₂

  • Molecular Weight:319.4

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and X-ray crystallography for stereostructure, suitable for cis-isomer impurity analysis of Epalrestat.

  • Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.1% in methanol-water solution within 6 months.

Applications

  • Quality Control Testing:Used for UPLC-MS/MS detection of (Z,Z)-isomer in Epalrestat API and formulations, controlling impurity content to meet ICH Q3A standards (≤0.1%).

  • Process Optimization Research:Monitors cis-isomer formation during Epalrestat synthesis, reducing generation by >50% by adjusting condensation temperature (e.g., 0-5℃) and reaction time.

  • Method Validation:Serves as a chiral standard for developing isomer separation methods, verifying UPLC resolution (≥3.0) and LOD (0.005 ng/mL).

Background Description

Epalrestat, an aldose reductase inhibitor, is used for treating diabetic neuropathy. The (Z,Z)-isomer, as a cis-impurity, may originate from stereoselective side reactions during allylation in synthesis or configuration conversion under high temperature and acidic conditions. Its thioxothiazolidine ring and phenyl structure may affect drug stability and efficacy. With stricter EMA requirements for chiral impurity control, studying such cis-impurities is key to ensuring drug quality.

Research Status

  • Detection Technology:UPLC-MS/MS with Chiralpak IA column (1.7μm) and n-hexane-ethanol (85:15) gradient elution achieves separation within 4.5 minutes, with LOD of 0.002 ng/mL for trace chiral impurity analysis.

  • Formation Mechanism:Formed by reaction of 2-methyl-3-phenylacrolein with thioxothiazolidinone under alkaline conditions (e.g., sodium carbonate catalysis). Using enzymatic catalysis (e.g., lipase) or asymmetric catalysis reduces cis-impurity formation by >80%.

  • Safety Evaluation:In vitro cytotoxicity shows IC₅₀ of 182.5 μM against HepG2 cells (Epalrestat IC₅₀=12.6 μM), with low toxicity but requiring ≤0.1% limit. Accelerated stability testing is ongoing to monitor configuration conversion rates under different pH conditions.


We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.

This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 







Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-02-06
$30.00/1mg
VIP6Y
TargetMol Chemicals Inc.
2025-11-10
$196.00/2mg
VIP4Y
TargetMol Chemicals Inc.
2025-07-26
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-02-06
INQUIRY